Schwartz Jeffrey Lawrence

SEC CIK: 0001702957

SEC filings (opens in a new tab)

In the past year, 1 open-market sale filing worth $97.9K and no purchases.

Current role at each company

KMTS Kestra Medical Technologies, Ltd.Director, 10% Owneras of Sep 10, 2026
RPID Rapid Micro Biosystems, Inc.Director, 10% Owneras of May 28, 2024
SWTX SpringWorks Therapeutics, Inc.Directoras of May 25, 2023

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: –; 0 filings
Sold: $97.9K; 1 filing
Net: −$97.9K; Bought minus sold
Companies: 1; With open-market trades

Trades

Every Form 4 that lists Schwartz Jeffrey Lawrence as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

KMTS Kestra Medical Technologies, Ltd.

Director, 10% Owner1 trade

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Sep 10, 2026 (view filing)8:43 PM ET	Sep 8	2 days	Schwartz Jeffrey LawrenceDirector, 10% Owner	SSale	−3.89K	$25.18	−$97.9K	−35.7%7.02K after

SWTX SpringWorks Therapeutics, Inc.

Director2 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Mar 20, 2023 (view filing)	Mar 16	4 days	Schwartz Jeffrey LawrenceDirector	SSale	−1.75M	$28.50	−$49.9M	−36.2%3.08M after
Aug 12, 2021 (view filing)8:38 PM ET	Aug 10	2 days	Schwartz Jeffrey Lawrence and 3 othersDirector, 10% Owner	SSale	−1.00M	$70.25	−$70.3M	−17.1%4.83M after

RPID Rapid Micro Biosystems, Inc.